ResearcherHospital de Clínicas de Porto AlegreNo recent work listed

Taiane Francieli Rebelatto

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7306-5428; OpenAlex author ID A5086430404. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2019: 1 paper

Papers 1

Should platinum-based chemotherapy be preferred for germline BReast CAncer genes (BRCA) 1 and 2-mutated pancreatic ductal adenocarcinoma (PDAC) patients? A sys… Co-author DOI 10.1016/j.ctrv.2019.101895 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Nicola Fazio · 1 shared paper, 2019 · strength 0.10
- Paper Should platinum-based chemotherapy be preferred for germline BReast CAncer genes (BRCA) 1 and 2-mutated pancreatic duct… DOI 10.1016/j.ctrv.2019.101895 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.